机译:E2f1-3从祖细胞中的活化剂切换到分化细胞中的阻遏物
Department of Molecular Virology, Immunology and Medical Genetics, College of Medicine Ohio 43210, USA Department of Molecular Genetics, College of Biological Sciences Ohio 43210, USA Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210, USA;
Department of Molecular Virology, Immunology and Medical Genetics, College of Medicine Ohio 43210, USA Department of Molecular Genetics, College of Biological Sciences Ohio 43210, USA Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210, USA Division of Pediatric Hematology/Oncology, Children's Hospital Boston Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, USA;
Department of Biological Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA;
Department of Molecular Virology, Immunology and Medical Genetics, College of Medicine Ohio 43210, USA Department of Molecular Genetics, College of Biological Sciences Ohio 43210, USA Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210, USA;
Department of Molecular Virology, Immunology and Medical Genetics, College of Medicine Ohio 43210, USA Department of Molecular Genetics, College of Biological Sciences Ohio 43210, USA Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210, USA;
Department of Molecular Virology, Immunology and Medical Genetics, College of Medicine Ohio 43210, USA Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210, USA;
Department of Molecular Virology, Immunology and Medical Genetics, College of Medicine Ohio 43210, USA Department of Molecular Genetics, College of Biological Sciences Ohio 43210, USA Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210, USA;
Department of Molecular Virology, Immunology and Medical Genetics, College of Medicine Ohio 43210, USA Department of Molecular Genetics, College of Biological Sciences Ohio 43210, USA Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210, USA;
Department of Molecular Virology, Immunology and Medical Genetics, College of Medicine Ohio 43210, USA Department of Molecular Genetics, College of Biological Sciences Ohio 43210, USA Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210, USA;
Department of Molecular Virology, Immunology and Medical Genetics, College of Medicine Ohio 43210, USA Department of Molecular Genetics, College of Biological Sciences Ohio 43210, USA Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210, USA;
Department of Molecular Virology, Immunology and Medical Genetics, College of Medicine Ohio 43210, USA Department of Molecular Genetics, College of Biological Sciences Ohio 43210, USA Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210, USA;
Department of Molecular Virology, Immunology and Medical Genetics, College of Medicine Ohio 43210, USA Department of Molecular Genetics, College of Biological Sciences Ohio 43210, USA Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210, USA;
Department of Molecular Virology, Immunology and Medical Genetics, College of Medicine Ohio 43210, USA Department of Molecular Genetics, College of Biological Sciences Ohio 43210, USA Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210, USA;
Department of Molecular Virology, Immunology and Medical Genetics, College of Medicine Ohio 43210, USA Department of Molecular Genetics, College of Biological Sciences Ohio 43210, USA Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210, USA;
Cambridge Research Institute, Li Ka Shing Centre, Cambridge CB2 ORE, UK;
The Beatson Institute for Cancer Research, Glasgow G61 1BD, UK;
Toronto Western Research Institute, University Health Network, Departments of Ophthalmology and Visual Science, and Laboratory Medicine and Pathobiology, University of Toronto, Ontario M5T 2S8, Canada;
Toronto Western Research Institute, University Health Network, Departments of Ophthalmology and Visual Science, and Laboratory Medicine and Pathobiology, University of Toronto, Ontario M5T 2S8, Canada;
Department of Biological Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA;
Department of Zoology, Miami University, Oxford, Ohio 45056, USA;
Department of Biological Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA;
Department of Molecular Virology, Immunology and Medical Genetics, College of Medicine Ohio 43210, USA Department of Molecular Genetics, College of Biological Sciences Ohio 43210, USA Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210, USA;
机译:活化T细胞的核因子(NFAT)蛋白通过其与乳膏(DVL)蛋白的相互作用抑制规范WNT信号传导,并参与调节神经祖细胞增殖和分化
机译:人骨髓和骨膜来源的祖细胞的间充质干细胞的粘附和机械调节人骨髓和骨膜来源的祖细胞的间质干细胞分化的粘附和机械调控人骨间质干细胞分化的粘附和机械调控骨髓和骨膜来源的祖细胞
机译:前叉蛋白FoxO1充当抑制人类胎儿胰腺祖细胞分化的阻遏物。
机译:在神经祖细胞分化期间,肽的自上而下的无标签LC-MALDI分析鉴定了祖细胞标记物
机译:T卵泡调节细胞促进生发中心反应和过敏性IgE反应,同时抑制T卵泡辅助细胞的异常分化
机译:E2F1-3从祖细胞中的活化剂切换到差异细胞中的阻遏物
机译:E2f1-3从祖细胞中的激活剂转变为分化细胞中的阻遏物